These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 19553799

  • 41. Modulating the tumor microenvironment to improve radiotherapy.
    Maity A.
    Retina; 2009 Jun; 29(6 Suppl):S32-3. PubMed ID: 19553796
    [Abstract] [Full Text] [Related]

  • 42. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
    Crawford Y, Ferrara N.
    Methods Enzymol; 2008 Jun; 445():125-39. PubMed ID: 19022058
    [Abstract] [Full Text] [Related]

  • 43. Age-related macular degeneration.
    Arden GB.
    J Br Menopause Soc; 2006 Jun; 12(2):64-70. PubMed ID: 16776857
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Emerging therapies for the treatment of neovascular age related macular degeneration.
    Yuan A, Kaiser PK.
    Semin Ophthalmol; 2011 May; 26(3):149-55. PubMed ID: 21609228
    [Abstract] [Full Text] [Related]

  • 46. [Experience with vascular endothelial growth factor inhibitors used in ophthalmologic care].
    Khalaim AV, Stoliarenko GE.
    Vestn Oftalmol; 2007 May; 123(5):54-6, preceding 56. PubMed ID: 18078062
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Retinal and choroidal microangiopathies: therapeutic opportunities.
    Afzal A, Shaw LC, Ljubimov AV, Boulton ME, Segal MS, Grant MB.
    Microvasc Res; 2007 May; 74(2-3):131-44. PubMed ID: 17585951
    [Abstract] [Full Text] [Related]

  • 49. VEGF is clearly an exciting point of attack in the treatment of neovascular diseases of the retina and choroid.
    Coimbra JC.
    Ophthalmologica; 2012 May; 227 Suppl 1():1. PubMed ID: 22645747
    [No Abstract] [Full Text] [Related]

  • 50. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M.
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [Abstract] [Full Text] [Related]

  • 51. Protein transport to choroid and retina following periocular injection: theoretical and experimental study.
    Mac Gabhann F, Demetriades AM, Deering T, Packer JD, Shah SM, Duh E, Campochiaro PA, Popel AS.
    Ann Biomed Eng; 2007 Apr; 35(4):615-30. PubMed ID: 17277991
    [Abstract] [Full Text] [Related]

  • 52. Radiotherapy for age-related macular degeneration: no more pilot studies please.
    Goverdhan SV, Gibbs FA, Lotery AJ.
    Eye (Lond); 2005 Nov; 19(11):1137-41. PubMed ID: 15543181
    [No Abstract] [Full Text] [Related]

  • 53. Putting theories and results into practice: managing cases.
    Nguyen QD, Do DV, Haller JA, Heier JS, Kaiser PK.
    Ophthalmology; 2013 May; 120(5 Suppl):S16-22. PubMed ID: 23642782
    [Abstract] [Full Text] [Related]

  • 54. Perfused, but not leaking.
    Prenner JL, Kaiser R, Chang TS.
    Ophthalmology; 2009 Aug; 116(8):1590, 1590.e1-2. PubMed ID: 19651318
    [No Abstract] [Full Text] [Related]

  • 55. Clinicopathologic correlation of progressive fibrovascular proliferation associated with occult choroidal neovascularization in age-related macular degeneration.
    Csaky K, Baffi J, Chan CC, Byrnes GA.
    Arch Ophthalmol; 2004 Apr; 122(4):650-2. PubMed ID: 15078686
    [No Abstract] [Full Text] [Related]

  • 56. New treatments for neovascular age-related macular degeneration: when should we use them?
    Kvanta A.
    Acta Ophthalmol Scand; 2007 Feb; 85(1):5. PubMed ID: 17244203
    [No Abstract] [Full Text] [Related]

  • 57. Ocular drug development--future directions.
    Sherris D.
    Angiogenesis; 2007 Feb; 10(2):71-6. PubMed ID: 17372850
    [Abstract] [Full Text] [Related]

  • 58. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration.
    Tsuchihashi T, Mori K, Peyman G, Shimada Y, Yoneya S.
    Retina; 2009 Feb; 29(10):1450-6. PubMed ID: 19816240
    [Abstract] [Full Text] [Related]

  • 59. Angiogenesis inhibitors: an upcoming therapy for cancer and wet age-related macular degeneration.
    Sweeney K.
    Drug Discov Today; 2005 Oct 15; 10(20):1346-8. PubMed ID: 16253870
    [No Abstract] [Full Text] [Related]

  • 60. Is IL-10 a good target to inhibit choroidal neovascularisation in age-related macular disease?
    Lightman S, Calder V.
    PLoS Med; 2006 Aug 15; 3(8):e364. PubMed ID: 16903781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.